Takeda Keeps Widening Global Footprint in $250M Multilab Buy

Only weeks after disclosing its goal of expanding into emerging markets in its 2012-2014 Mid-Range Plan, Takeda Pharmaceutical Co. Ltd. made a move in Brazil with the acquisition of Multilab Industria e Comercio de Produtos Farmaceuticos Ltda. for BRL500 million (US$249.9 million) up front and up to BRL40 million in future milestones.